- Home
- DTI vs STRO Comparison
DTI vs STRO Comparison
Compare DTI & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTI
- STRO
- Stock Information
- Founded
- DTI 1984
- STRO 2003
- Country
- DTI United States
- STRO United States
- Employees
- DTI N/A
- STRO N/A
- Industry
- DTI Metal Fabrications
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DTI Industrials
- STRO Health Care
- Exchange
- DTI Nasdaq
- STRO Nasdaq
- Market Cap
- DTI 68.0M
- STRO 77.7M
- IPO Year
- DTI N/A
- STRO 2018
- Fundamental
- Price
- DTI $3.00
- STRO $0.75
- Analyst Decision
- DTI Strong Buy
- STRO Hold
- Analyst Count
- DTI 1
- STRO 7
- Target Price
- DTI $5.50
- STRO $3.97
- AVG Volume (30 Days)
- DTI 125.9K
- STRO 1.4M
- Earning Date
- DTI 08-05-2025
- STRO 08-12-2025
- Dividend Yield
- DTI N/A
- STRO N/A
- EPS Growth
- DTI N/A
- STRO N/A
- EPS
- DTI N/A
- STRO N/A
- Revenue
- DTI $160,352,000.00
- STRO $66,434,000.00
- Revenue This Year
- DTI $2.22
- STRO N/A
- Revenue Next Year
- DTI $2.11
- STRO N/A
- P/E Ratio
- DTI N/A
- STRO N/A
- Revenue Growth
- DTI 8.19
- STRO N/A
- 52 Week Low
- DTI $1.43
- STRO $0.52
- 52 Week High
- DTI $6.36
- STRO $5.17
- Technical
- Relative Strength Index (RSI)
- DTI 50.62
- STRO 38.33
- Support Level
- DTI $2.91
- STRO $0.76
- Resistance Level
- DTI $3.27
- STRO $0.87
- Average True Range (ATR)
- DTI 0.25
- STRO 0.07
- MACD
- DTI -0.05
- STRO -0.01
- Stochastic Oscillator
- DTI 12.95
- STRO 0.00
About DTI Drilling Tools International Corporation
Drilling Tools International Corp manufactures, rents, inspects, and refurbishes downhole drilling tools primarily to companies in the oil and natural gas industry for bottom hole assemblies used in onshore and offshore horizontal and directional drilling. The company's United States operations have locations in Texas, California, Louisiana, Oklahoma, Pennsylvania, North Dakota, New Mexico, Utah, and Wyoming. The company's single segment derives revenues from customers by providing oilfield equipment and services to operators in the oil and natural gas sectors.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.